Hexanedioic acid, polymer with hexahydro-2H-azepin-2-one, bis(4-aminocyclohexylmethane and 1,6-hexanediamine (Nylon 6/66
General Information
Mainterm | Hexanedioic acid, polymer with hexahydro-2H-azepin-2-one, bis(4-aminocyclohexylmethane and 1,6-hexanediamine (Nylon 6/66 |
CAS Reg.No.(or other ID) | 25053-13-8 |
Regnum |
From www.fda.gov
Computed Descriptors
Download SDF2D Structure | |
CID | 168260 |
IUPAC Name | 4-[(4-aminocyclohexyl)methyl]cyclohexan-1-amine;azepan-2-one;hexane-1,6-diamine;hexanedioic acid |
InChI | InChI=1S/C13H26N2.C6H16N2.C6H11NO.C6H10O4/c14-12-5-1-10(2-6-12)9-11-3-7-13(15)8-4-11;7-5-3-1-2-4-6-8;8-6-4-2-1-3-5-7-6;7-5(8)3-1-2-4-6(9)10/h10-13H,1-9,14-15H2;1-8H2;1-5H2,(H,7,8);1-4H2,(H,7,8)(H,9,10) |
InChI Key | LYRSKWHPYTWGPJ-UHFFFAOYSA-N |
Canonical SMILES | C1CCC(=O)NCC1.C1CC(CCC1CC2CCC(CC2)N)N.C(CCCN)CCN.C(CCC(=O)O)CC(=O)O |
Molecular Formula | C31H63N5O5 |
From Pubchem
Computed Properties
Property Name | Property Value |
---|---|
Molecular Weight | 585.875 |
Hydrogen Bond Donor Count | 7 |
Hydrogen Bond Acceptor Count | 9 |
Rotatable Bond Count | 12 |
Complexity | 393.0 |
CACTVS Substructure Key Fingerprint | A A A D c f B 7 u A A A A A A A A A A A A A A A A A A A A A A A A A A w Y A A A B Y A A A A A A A A A A H g A Q C A A A D S j B g A Q A C A L A A g A I A A G Q G A A A A A A A A A A A A I E I A A A A A B I A g A A E Q A A E F g C A A A G Y y M A O A A A A A A A A A A A Q A A A A A A A A A A A A A A A A A A = = |
Topological Polar Surface Area | 208.0 |
Monoisotopic Mass | 585.483 |
Exact Mass | 585.483 |
Compound Is Canonicalized | True |
Formal Charge | 0 |
Heavy Atom Count | 41 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Isotope Atom Count | 0 |
Covalently-Bonded Unit Count | 4 |
From Pubchem
ADMET Predicted Profile --- Classification
Model | Result | Probability |
---|---|---|
Absorption | ||
Blood-Brain Barrier | BBB+ | 0.8761 |
Human Intestinal Absorption | HIA- | 0.6265 |
Caco-2 Permeability | Caco2- | 0.7512 |
P-glycoprotein Substrate | Substrate | 0.5695 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.9535 |
Non-inhibitor | 0.9695 | |
Renal Organic Cation Transporter | Non-inhibitor | 0.7731 |
Distribution | ||
Subcellular localization | Mitochondria | 0.5955 |
Metabolism | ||
CYP450 2C9 Substrate | Non-substrate | 0.8329 |
CYP450 2D6 Substrate | Non-substrate | 0.8319 |
CYP450 3A4 Substrate | Non-substrate | 0.6207 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.9177 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.9507 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9256 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.9579 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.8955 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9890 |
Excretion | ||
Toxicity | ||
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9901 |
Non-inhibitor | 0.7003 | |
AMES Toxicity | Non AMES toxic | 0.8592 |
Carcinogens | Non-carcinogens | 0.9588 |
Fish Toxicity | Low FHMT | 0.7014 |
Tetrahymena Pyriformis Toxicity | Low TPT | 0.8941 |
Honey Bee Toxicity | Low HBT | 0.8278 |
Biodegradation | Not ready biodegradable | 0.6719 |
Acute Oral Toxicity | III | 0.5864 |
Carcinogenicity (Three-class) | Non-required | 0.6465 |
From admetSAR
ADMET Predicted Profile --- Regression
Model | Value | Unit |
---|---|---|
Absorption | ||
Aqueous solubility | -2.5916 | LogS |
Caco-2 Permeability | 0.1789 | LogPapp, cm/s |
Distribution | ||
Metabolism | ||
Excretion | ||
Toxicity | ||
Rat Acute Toxicity | 1.8296 | LD50, mol/kg |
Fish Toxicity | 2.2615 | pLC50, mg/L |
Tetrahymena Pyriformis Toxicity | -0.2726 | pIGC50, ug/L |
From admetSAR